Home
>
National Drug Code (NDC)
>
EryPed 200
EryPed 200 - 0074-6302-13 - (Erythromycin Ethylsuccinate)
Drug Information of EryPed 200
| Product NDC: | 0074-6302 |
| Proprietary Name: | EryPed 200 |
| Non Proprietary Name: | Erythromycin Ethylsuccinate |
| Active Ingredient(s): | 200 mg/5mL & nbsp; Erythromycin Ethylsuccinate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of EryPed 200
| Product NDC: | 0074-6302 |
| Labeler Name: | Abbott Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050207 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101201 |
Package Information of EryPed 200
| Package NDC: | 0074-6302-13 |
| Package Description: | 100 mL in 1 BOTTLE (0074-6302-13) |
NDC Information of EryPed 200
| NDC Code | 0074-6302-13 |
| Proprietary Name | EryPed 200 |
| Package Description | 100 mL in 1 BOTTLE (0074-6302-13) |
| Product NDC | 0074-6302 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Erythromycin Ethylsuccinate |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20101201 |
| Marketing Category Name | NDA |
| Labeler Name | Abbott Laboratories |
| Substance Name | ERYTHROMYCIN ETHYLSUCCINATE |
| Strength Number | 200 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |
